electroCore (ECOR) Completes Acquisition of NeuroMetrix
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
May 2, 2025 8:00 AM EDTROCKAWAY, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (ECOR, electroCore, or the Company) (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, announced today the completion of the merger (the Merger) with NeuroMetrix, Inc. (NeuroMetrix or NURO) (Nasdaq: NURO), positioning itself as a diversified leader in non-invasive health and wellness solutions.
The acquisition of NeuroMetrixs Quell® Fibromyalgia Solution expands electroCores portfolio of non-invasive bioelectronic therapies, strengthens its commercial reach particularly within the VA Hospital System and is expected to meaningfully increase its addressable market for the treatment of chronic pain and wellness conditions.
Dan Goldberger, CEO... More
